Recombinant Human Interleukin-13 Variant (rHuIL-13 variant)

Produktübersicht

• Artikelname: Recombinant Human Interleukin-13 Variant (rHuIL-13 variant)
• Artikelnummer: BWT-PR1061
• Hersteller Artikelnummer: PR1061
• Alternativnummer: BWT-PR1061-2UG,BWT-PR1061-10UG,BWT-PR1061-1.0MG
• Hersteller: Bioworld Technology
• Kategorie: Biochemikalien

Produktbeschreibung

The human IL-13 cDNA encodes a 132 amino acid protein containing a proposed 20 amino acid signal peptide. Human IL-13 shares approximately 30% amino acid sequence homology to human IL-4 and the two cytokines exhibit overlapping biological activities. Hum

Produkteigenschaften

• Molekulargewicht: Approximately 12.5 kDa, a single non-glycosylated polypeptide chain containing 114 amino acids, with a substitution of Q for R at position 112 compared with the wild type IL-13.
• Quelle: Escherichia coli.
• Reinheit: >95% by SDS-PAGE and HPLC analyses.
• Formulierung: Sterile Filtered White lyophilized (freeze-dried) powder.
• Sequenz: SPGPVPPSTA LRELIEELVN ITQNQKAPLC NGSMVWSINL TAGMYCAALE SLINVSGCSA IEKTQRMLSG FCPHKVSAGQ FSSLHVRDTK IEVAQFVKDL LLHLKKLFRE GQFN
• Formel: Lyophilized from a 0.2m filtered concentrated solution in PBS, pH 7.2, containing 5% trehalose.

Anwendungsbeschreibung

• Anwendungsbeschreibung: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/ml. Stock solutions should be apportio